Great West Life Assurance CO Intra Cellular Therapies, Inc. Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

A detailed history of Great West Life Assurance CO transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 21,498 shares of ITCI stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,498

Previous 20,187 6.49%

Holding current value

$1.84 Million

Previous $1.38 Million 13.96%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$67.99 - $80.84 $89,134 - $105,981	1,311 Added 6.49%	21,498 $1.58 Million
Q2 2024 Aug 12, 2024	BUY	$64.76 - $79.84 $204,900 - $252,613	3,164 Added 18.59%	20,187 $1.38 Million
Q1 2024 May 13, 2024	BUY	$64.37 - $75.65 $563,881 - $662,694	8,760 Added 106.01%	17,023 $1.18 Million
Q4 2023 Feb 13, 2024	BUY	$46.37 - $73.65 $29,027 - $46,104	626 Added 8.2%	8,263 $587,000
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $213,569 - $262,810	4,100 Added 115.92%	7,637 $398,000
Q2 2023 Aug 10, 2023	SELL	$54.67 - $66.44 $41,111 - $49,962	-752 Reduced 17.53%	3,537 $225,000
Q3 2022 Nov 01, 2022	BUY	$42.7 - $59.99 $183,140 - $257,297	4,289 New	4,289 $199,000
Q2 2022 Aug 09, 2022	BUY	$43.0 - $65.64 $13,115 - $20,020	305 Added 7.66%	4,289 $245,000
Q1 2022 May 12, 2022	BUY	$38.74 - $62.09 $19,486 - $31,231	503 Added 14.45%	3,984 $259,000
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $20,873 - $31,678	-593 Reduced 14.56%	3,481 $181,000
Q2 2021 Aug 11, 2021	SELL	$29.3 - $44.5 $27,864 - $42,319	-951 Reduced 18.93%	4,074 $166,000
Q1 2021 May 17, 2021	BUY	$30.8 - $39.51 $25,163 - $32,279	817 Added 19.42%	5,025 $169,000
Q3 2020 Nov 17, 2020	SELL	$17.61 - $31.86 $5.64 Million - $10.2 Million	-320,192 Reduced 98.7%	4,208 $107,000
Q3 2020 Nov 13, 2020	BUY	$17.61 - $31.86 $5.64 Million - $10.2 Million	320,192 Added 7609.13%	324,400 $8.32 Million
Q4 2019 Feb 11, 2020	BUY	$7.26 - $38.49 $30,550 - $161,965	4,208 New	4,208 $144,000
Q3 2019 Oct 25, 2019	SELL	$7.47 - $14.03 $27,773 - $52,163	-3,718 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$10.65 - $14.29 $287 - $385	-27 Reduced 0.72%	3,718 $0
Q3 2017 Nov 09, 2017	BUY	$10.77 - $22.1 $40,333 - $82,764	3,745	3,745 $58,000

Others Institutions Holding ITCI

# of Institutions

377

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.09B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Intra Cellular Therapies, Inc. Transaction History